Searching journal content for articles similar to Cao et al. 23 (12): T199.

Displaying results 1-10 of 10
For checked items
  1. ..." androgen receptor " splice variants " castration resistant prostate cancer " AR variants " metastasis " epithelial to mesenchymale rt o CaKathryn E Ware1, Mariano A Garcia-Blanco1,2, Andrew J Armstrong1,2 andBiologic and clinical sign androgen receptor varia castration resistant proscance of ts in te...
  2. ...) Abstract With few exceptions, the almost 30,000 prostate cancer deaths annually in the United States are due to failure of androgen deprivation therapy. Androgen deprivation therapy prevents ligand-activation of the androgen receptor. Despite initial remission after androgen deprivation therapy, prostate...
  3. ...roles in pathophysiology of prostate cancer. Steroid receptors Androgen receptor (AR or NR3C4) Tumours not cured by surgery or radiotherapy are treated by blocking the action of AR. However, despite this, it has only been since the mid-90s that we have become aware of the importance of androgen...
  4. .... Recent studies suggest that there is a higher than expected association between prostate cancer and bladder cancer (Marcinkiewicz et al. 2012). This suggests that AR signaling may be one DHT P P HSP HSP STAT3 MAPK RAS IL IL-R GF RTK AKTSRC Review A P Lombard and M Mudryj Androgen receptor in bladder...
  5. ...are important for normal prostate architecture, homeostasis, AR protein N-terminal domain DNA-bind Zn++ NH2– Figure 1 Androgen receptor structure.X chromosomeand physiological function. In prostate cancer (PCa) cells, expression of these genes leads to the proliferation and survival of tumor cells. In breast...
  6. ...of CDK and cyclin proteins in premetazoan lineages. BMC Evolutionary Biology 14 1–16. (doi:10.1186/1471-2148- 14-10) Chan SC, Li Y & Dehm SM 2012 Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen...
  7. ...disassembly and suppressed breast cancer cell migration and invasion (Xu et al. 2010). Similarly, in prostate cancer, FlnA binding promoted androgen receptor (AR) localization to the nucleus (Ozanne et al. 2000), which is thought to promote prostate cancer progression; however, once in the nucleus...
  8. ...-STAT5A/B and androgen receptor (AR) signaling in prostate cancer cells. Binding of prolactin (PRL) to prolactin receptor (PRLR) results in receptor dimerization and activates the receptor associated kinase, Janus kinase 2 (JAK2). JAK2 phosphorylates the PRLR on tyrosine residues, thereby creating...
  9. ...), consistent with a role in epithelial differentiation. More insight into the molecular mechanisms by which this occurs has recently been published using immortalized prostate epithelial and prostate cancer cell line models (Mak et al. 2013). Furthermore, it was also shown that these effects were mediated...
  10. ...replacement therapy and ovarian cancer. Epidemiology 15 100–104. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M & Inoue S 2001 Differential expression of estrogen receptor b (ERb) and its C-terminal truncated splice variant ERbcx as prognostic predictors in human prostatic cancer...
For checked items